# Dose Ranging Study of Indacaterol in Japanese Patients With Chronic Obstructive Pulmonary Disease (COPD)

> **NCT00403845** · PHASE2 · COMPLETED · sponsor: **Novartis** · enrollment: 50 (actual)

## Conditions studied

- Chronic Obstructive Pulmonary Disease

## Interventions

- **DRUG:** Indacaterol 150 μg
- **DRUG:** Indacaterol 300 μg
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00403845
- **Lead sponsor:** Novartis
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-12
- **Primary completion:** 2007-10
- **Final completion:** 2007-10
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2011-08-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00403845

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00403845, "Dose Ranging Study of Indacaterol in Japanese Patients With Chronic Obstructive Pulmonary Disease (COPD)". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00403845. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*